The annual global pharmaceutical industry event, FCE Pharma 2024 (Brazil International Pharmaceutical Ingredients Exhibition), was successfully held from June 4th to 6th at the São Paulo Northern Exhibition Center in Brazil. As an innovative representative of China’s high-end new medical materials field, Shanghai JSD New Medical Material Co., Ltd (hereinafter referred to as “JSD”) launched its innovative co-injection cap product for blow-fill-seal (BFS) technology infusion bottles at the exhibition. With its superior technology and performance, it sets a new benchmark for the safety and efficiency of large-volume infusion packaging globally, becoming a major focus of attention during the exhibition.
BFS technology, as an advanced aseptic manufacturing process, is increasingly widely used in the field of infusion products, placing extremely high demands on the sealing performance, compatibility, and ease of opening of packaging caps. JSD’s co-injection cap, showcased at the event, is tailor-made to address these core needs. This product employs an advanced multi-layer co-injection molding process, fusing polymer materials with different properties under precise control, cleverly achieving a perfect combination of “high mechanical strength in the outer layer and excellent sealing and compatibility in the inner layer”.
At the exhibition, JSD New Medical Material Co., through product demonstrations, cross-sectional structural analysis, and multimedia presentations, explained in detail the core advantages of its co-injection cap to pharmaceutical company representatives, technical experts, and buyers from around the world.
• Excellent seal integrity: Effectively prevents oxygen and moisture penetration, ensuring the sterility and stability of the medicine throughout its shelf life and significantly reducing the risk of leakage.
• Excellent drug compatibility: The inner contact material strictly adheres to pharmaceutical-grade standards, with extremely low dissolution and exudation, fully ensuring the safety of sensitive drugs.
• The user-friendly opening design balances ease of opening with clear identification of broken rings, facilitating operation by medical staff while ensuring medication safety and preventing reuse.
• Strong production line adaptability: The product design is precisely matched with mainstream BFS high-speed filling production lines, demonstrating excellent stability and production efficiency.
JSD’s booth attracted a large number of attendees, particularly professionals from major South American and international pharmaceutical companies, who showed strong interest in collaborating on this innovative solution. Many clients engaged in in-depth technical exchanges on-site, highly praising the samples and reaching several preliminary cooperation and testing agreements.
The Overseas Market Director of Shanghai JSD New Medical Material Co., Ltd stated at the exhibition: “We are very pleased to launch our strategic product—BFS infusion bottle co-injection caps—to the global market on the international stage of FCE Pharma. The South American market is a key area for the application of BFS technology, and we deeply understand the needs of local customers for high-quality packaging accessories. The enthusiastic response at this exhibition fully demonstrates the correctness of our innovative direction. JSD is committed to becoming the most trusted packaging solution partner for global pharmaceutical companies, and we will continue to contribute our professional strength to improving global drug safety and manufacturing standards, driven by technological innovation.”
The success of this trip to Brazil marks a significant step forward for Shanghai JSD New Medical Material Co., Ltd on its internationalization strategy. The company will continue to focus on the research and development of new medical materials, serving the global pharmaceutical and healthcare industry with a more diverse and advanced product line, and bringing the innovative achievements of “Made in China” to the world.
